Niven Mehra

48PUBLICATIONS
217CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (48)

|Jul 08, 2026
Shallow Whole-Genome Sequencing to Assess Genomic Instability and Predict Treatment Response in Metastatic Castration-Resistant Prostate Cancer.

|Jul 02, 2026
Germline CDK12 variants in aggressive prostate cancer.

|May 28, 2026
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.

|May 11, 2026
Detection of Homologous Recombination Repair Gene Mutations by Tumor Tissue and Circulating Tumor DNA Testing in Prostate Cancer in the Phase III PROpel Trial.

|Jan 23, 2026
Assessing the Detection Power of Genome-Wide Copy Number Variation Profiles in Prostate Cancer Using Simulated Shallow Whole-Genome Sequencing Data.

Samhita Pamidimarri Naga, Peter H J Slootbeek, Sofie H Tolmeijer

|Nov 01, 2025
Molecular reflex testing in patients with early metastatic castration-resistant prostate cancer within the PROMPT-study.

Iris S H Kloots, Peter H J Slootbeek, Sofie H Tolmeijer

Pageof 8

Frequent Collaborators

10 joint publications

Inge van Oort

9 joint publications

Peter H J Slootbeek

8 joint publications

Marjolijn Ligtenberg

7 joint publications

Diederik M Somford